Cytochrome P450 1B1 (CYP1B1) pharmacogenetics association of polymorphisms with functional differences in estrogen hydroxylation activity

Cancer Research

Volumn 60, Issue 13, 2000, Pages 3440-3444

  Hanna, Imad H ^a   Dawling, Sheila ^b   Roodi, Nady ^b   Guengerich, F Peter ^a   Parl, Fritz F ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 ISOENZYME; ESTROGEN; OXYGENASE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CARCINOGENICITY; CATALYSIS; ESTROGEN ACTIVITY; ESTROGEN METABOLISM; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HYDROXYLATION; PHARMACOGENETICS; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; ARYL HYDROCARBON HYDROXYLASES; CLONING, MOLECULAR; CODON; CYTOCHROME P-450 ENZYME SYSTEM; ESCHERICHIA COLI; ESTRADIOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; HYDROXYLATION; KINETICS; MUTAGENESIS, SITE-DIRECTED; PHARMACOGENETICS; POLYMORPHISM, GENETIC; RECOMBINANT PROTEINS; STEROID 16-ALPHA-HYDROXYLASE; VARIATION (GENETICS);

EID: 0034234293     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Abul-Hajj, Y. J., and Cisek, P. L. Catechol estrogen adducts. J. Steroid Biochem., 31: 107-110, 1988.
2. Dwivedy, I., Devanesan, P., Cremonesi, P., Rogan, E., and Cavalieri, E. Synthesis and characterization of estrogen 2,3-and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens. Chem. Res. Toxicol., 5: 828-833, 1992.
3. Liehr, J. G., Ulubelen, A. A., and Strobel, H. W. Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem., 261: 16865-16870, 1986.
4. Liehr, J. G. Genotoxic effects of estrogens. Mutat. Res., 238: 269-276, 1990.
5. Liehr, J. G., and Roy, D. Free radical generation by redox cycling of estrogens. Free Radical Biol. Med., 8: 415-423, 1990.
6. Nutter, L. M., Wu, Y. Y., Ngo, E. O., Sierra, E. E., Gutierrez, P. L., and Abul-Hajj, Y. J. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem. Res. Toxicol., 7: 23-28, 1994.
7. Osborne, M. P., Bradlow, H. L., Wong, G. Y. C., and Telang, N. T. Upregulaton of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Inst., 85: 1917-1920, 1993.
8. Nebert, D. W. Elevated estrogen 16α-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk? J. Natl. Cancer Inst., 85: 1888-1891, 1993.
9. Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K., and Kaminsky, L. S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos., 24: 899-905, 1996.
10. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56: 2979-2984, 1996.
11. Spink, D. C., Eugster, H., Lincoln, D. W. I., Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S., and Gierthy, J. F. 17 β-estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293: 342-348, 1992.
12. Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., and Gierthy, J. F. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 β-estradiol 4-hydroxylase. J. Steroid Biochem. Mol. Biol., 51: 251-258, 1994.
13. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
14. Li, J. J., and Li, S. A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46: 1858-1863, 1987.
15. Liehr, J. G., Fang, W. F., Sirbasku, D. A., and Ari-Ulubelen, A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem., 24: 353-356, 1986.
16. Han, X., and Liehr, J. G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis (Lond.), 16: 2571-2574, 1995.
17. Han, X., and Liehr, J. G. DNA single-strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens: hormone-induced free radical damage preceding renal malignancy. Carcinogenesis (Lond.), 15: 997-1000, 1994.
18. Cavalieri, E. L., Stack, D.E., Devanesan, P. D., Todorvic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Paul, K. D., Gross, M. L., Gooden, J. K., Ramanathan, R., and Cerny, R. L. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc. Natl. Acad. Sci. USA, 94: 10937-10942, 1997.
19. Newbold, R. R., and Liehr, J. G. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res., 60: 235-237, 2000.
20. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
21. Stoilov, I., Akarsu, A. N., and Sarfarazi, M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet., 6: 641-647, 1997.
22. Bejjani, B. A., Lewis, R. A., Tomey, K. F., Andersen, K. L., Dueker, D. K., Jabak, M., Astle, W. F., Otterud, B., Leppert, M., and Lupski, J. R. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudia Arabia. Am. J. Hum. Genet., 62: 325-333, 1998.
23. Stoilov, I., Akarsu, A. N., Alozie, I., Child, A., Barsoum-Hornsy, M., Turacli, M. E., Or, M., Lewis, R. A., Ozdemir, N., Brice, G., Aktan, S. G., Chevrette, L., Coca-Prados, M., and Sarfarazi, M. Sequence analysis and homology modeling suggest primary congenital glaucoma on 2p21 results from mutations disrupting either the hinge region or the conserved core structures of cytochrome P450 1B1. Am. J. Hum. Genet., 62: 573-584, 1998.
24. Bailey, L. R., Roodi, N., Dupont, W. D., and Parl, F. F. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. [Erratum: Cancer Res., 59: 1388, 1999.] Cancer Res., 58: 5038-5041, 1998.
25. Gillam, E. M., Guo, Z., Ueng, Y. F., Yamazaki, H., Cock, I., Reilly, P. E., Hooper, W. D., and Guengerich, F. P. Expression of cytochrome P450 3A5 in Escherichia coli: effects of 5′ modification, purification, spectral characterization, reconstitution conditions, and catalytic activities. Arch. Biochem. Biophys., 317: 374-384, 1995.
26. Guengerich, F. P. Oxidation-reduction properties of rat liver cytochromes P-450 and NADPH-cytochrome P-450 reductase related to catalysis in reconstituted systems. Biochemistry. 22: 2811-2820, 1983.
27. Omura, T., and Sato, R. The carbon monoxide-binding pigment of liver microsomes. I. evidence for its hemoprotein nature. J. Biol. Chem., 239: 2370-2378, 1964.
28. Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F. Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH-and hydroperoxide-supported activities. Arch. Biochem. Biophys., 350: 324-332, 1998.
29. Shimada, T., Wunsch, R. W., Hanna, I. H., Sutter, T. R., Guengerich, F. P., and Gillam, E. M. J. Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch Biochem Biophys., 357: 111-120, 1998.
30. Guengerich, F. P., Gillam, E. M., and Shimada, T. New applications of bacterial systems to problems in toxicology. Crit. Rev. Toxicol., 26: 551-583, 1996.
31. 2+-chelate affinity purification, and characterization of solubility and aggregation. Arch. Biochem. Biophys., 321: 277-288, 1995.
32. Aoyama, T., Korzekwa, K., Nagata, K., Gillette, J., Gelboin, H. V., and Gonzalez, F. J. Estradiol metabolism by complementary deoxyribomicleic acid-expressed human cytochrome P450s. Endocrinology, 126, 3101-3106, 1990.
33. Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Korzekwa, K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys., 290: 160-166, 1991.
34. Shimada, T., Watanabe, J., Kawajiri, K., Sutter, T. R., Guengerich, F. P., Gillam, E. M. J., and Inoue, K. Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis (Lond.), 20: 1607-1613, 1999.
35. Van Aswegen, C. H., Purdy, R. H., and Wittliff, J. L. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J. Steroid Biochem., 32: 485-492, 1989.
36. Schutze, N., Vollmer, G., Tiemann, I., Geiger, M., and Knuppen, R. Catecholestrogens are MCF-7 cell estrogen receptor agonists. J. Steroid Biochem. Mol. Biol., 46: 781-789, 1993.
37. Schutze, N., Vollmer, G., and Knuppen, R. Catecholestrogens are agonists of estrogen receptor dependent gene expression in MCF-7 cells. J. Steroid Biochem. Mol. Biol., 48: 453-461, 1994.
38. Barnea, E. R., MacLusky, N. J., and Naftolin, F. Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids, 41: 643-656, 1983.
39. Imoto, S., Mitani, F., Enomoto, K., Fujiwara, K., Ikeda, T., Kitajima, M., and Ishimura, Y. Influence of estrogen metabolism on proliferation of human breast cancer. Breast Cancer Res. Treat., 42: 57-64, 1997.
40. Berhane, K., Widersten, M., Engstrom, A., Kozarich, J. W., and Mannervik, B. Detoxification of base propenals and other α, β-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc. Natl. Acad. Sci. USA, 91: 1480-1484, 1994.
41. Roy, D., Weisz, J., and Liehr, J. G. The O-methylation of 4-hydroxyestradiol is inhibited by 2-hydroxyestradiol: implications for estrogen induced Carcinogenesis. Carcinogenesis (Lond.), 11: 459-462, 1990.
42. Iverson, S. L., Shen, L., Anlar, N., and Bolton, J. L. Bioactivation of estrone and its catechol metabolites to quinoid-glutathione conjugates in rat liver microsomes. Chem. Res, Toxicol., 9: 492-499, 1996.
43. Perera, F. P. Molecular epidemiology: insights into cancer susceptibility, risk assessment, and prevention. J. Natl. Cancer Inst., 88: 496-509, 1996.
44. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.